medigraphic.com
ISSN 0301-696X (Impreso)
Órgano de difusión del Servicio de Sanidad Militar y del Colegio Nacional de Médicos Militares

2018, Número 2

<< Anterior Siguiente >>

Rev Sanid Milit Mex 2018; 72 (2)


Trasplante cruzado y ABO incompatible. Cambio en el panorama tradicional de trasplante renal en México

Bahena CL

Idioma: Español
Referencias bibliográficas: 24
Paginas: 133-140
Archivo PDF: 202.71 Kb.


RESUMEN

Existen numerosos estudios que demuestran la superioridad en términos de sobrevida y calidad de vida del trasplante como terapia de sustitución renal en comparación con hemodiálisis y diálisis peritoneal. A nivel nacional y mundial las listas de espera aumentan desproporcionadamente en relación con el número de trasplantes realizados. Los diferentes gobiernos deben instituir medidas para garantizar la autosuficiencia de órganos en cada país, como los programas de intercambio de donantes y el ABOi, recursos ya probados en diferentes partes del mundo con adecuada seguridad y efectividad que pueden mejorar el índice de trasplantes ante alguna barrera inmunológica de la pareja donante-receptor.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Morris PJ, Knechtle SJ. Kidney transplantation: principles and practice. 7 ed. Philadelphia, PA: Saunders Elsevier; 2014. pp. 1-8.

  2. CENATRA [Internet]. México: Estadísticas. 2017. Available in: https://www.gob.mx/cms/uploads/attachment/file/245082/1ersemestre2017.pdf

  3. Akkina SK, Muster H, Steffens E, Kim SJ, Kasiske BL, Israni AK. Donor exchange programs in kidney transplantation: rationale and operational details from the north central donor exchange cooperative. Am J Kidney Dis. 2011; 57 (1): 152-158.

  4. Cuffy MC, Ratner LE, Siegler M, Woodle ES. Equipoise: ethical, scientific, and clinical trial design considerations for compatible pair participation in kidney exchange programs. Am J Transplant. 2015; 15 (6): 1484-1489.

  5. Ferrari P, Weimar W, Johnson RJ, Lim WH, Tinckam KJ. Kidney paired donation: principles, protocols and programs. Nephrol Dial Transplant. 2015; 30 (8): 1276-1285.

  6. Pham TA, Lee JI, Melcher ML. Kidney paired exchange and desensitization: Strategies to transplant the difficult to match kidney patients with living donors. Transplant Rev (Orlando). 2017; 31 (1): 29-34.

  7. De Klerk M, Van Der Deijl WM, Witvliet MD, Haase-Kromwijk BJ, Claas FH, Weimar W. The optimal chain length for kidney paired exchanges: an analysis of the Dutch program. Transpl Int. 2010; 23 (11): 1120-1125.

  8. Blumberg JM, Gritsch HA, Reed EF, Cecka JM, Lipshutz GS, Danovitch GM et al. Kidney paired donation in the presence of donor-specific antibodies. Kidney Int. 2013; 84 (5): 1009-1016.

  9. Sypek MP, Alexander SI, Cantwell L, Ierino FL, Ferrari P, Walker AM et al. Optimizing outcomes in pediatric renal transplantation through the Australian paired kidney exchange program. Am J Transplant. 2017; 17 (2): 534-541.

  10. Yücetin L, Tilif S, Keçecioğlu N, Yanik Ö, Özkan A, Eroğlu A et al. Paired exchange kidney transplantation experience of Turkey. Transplant Proc. 2013; 45 (3): 860-863.

  11. Kute VB, Patel HV, Shah PR, Modi PR, Shah VR, Rizvi SJ et al. Past, present and future of kidney paired donation transplantation in India. World J Transplant. 2017; 7 (2): 134-143.

  12. Ross LF, Rubin DT, Siegler M, Josephson MA, Thistlethwaite JR Jr, Woodle ES. Ethics of a paired-kidney-exchange program. N Engl J Med. 1997; 336 (24): 1752-1755.

  13. Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev (Orlando). 2013; 27 (1): 1-8.

  14. Brynger H, Rydberg L, Samuelsson B, Blohmé I, Lindholm A, Sandberg L. P Renal transplantation across a blood group barrier—‘A2’ kidneys to ‘O’ recipients. Proc Eur Dial Transplant Assoc. 1983; 19: 427-431.

  15. Rydberg L, Breimer ME, Samuelsson BE, Brynger H. Blood group ABO-incompatible (A2 to O) kidney transplantation in human subjects: a clinical, serologic, and biochemical approach. Transplant Proc. 1987; 19 (6): 4528-4537.

  16. Kawami H, Shiramizu T, Mori Y, Yayama T, Yonemura T, Oka N et al. A clinical case of ABO-incompatible living renal transplantation. Nihon Geka Gakkai Zasshi. 1990; 91 (8): 1044-1047.

  17. Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation. 2009; 87 (8): 1246-1255.

  18. Montgomery JR, Berger JC, Warren DS, James NT, Montgomery RA, Segev DL. Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation. 2012; 93 (6): 603-609.

  19. Tydén G, Donauer J, Wadström J, Kumlien G, Wilpert J, Nilsson T et al. Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations. Transplantation. 2007; 83 (9): 1153-1155.

  20. Wilpert J, Fischer KG, Pisarski P, Wiech T, Daskalakis M, Ziegler A et al. Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis. Nephrol Dial Transplant. 2010; 25 (11): 3778-3786.

  21. Opelz G, Morath C, Süsal C, Tran TH, Zeier M, Döhler B. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers. Transplantation. 2015; 99 (2): 400-404.

  22. Tobian AA, Shirey RS, Montgomery RA, Cai W, Haas M, Ness PM et al. ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. Am J Transplant. 2010; 10 (5): 1247-1253.

  23. Geyer M, Donauer J, Pisarski P, Drognitz O, Schulz-Huotari C, Wisniewski U et al. Preemptive postoperative antigen-specific immunoadsorption in ABO-incompatible kidney transplantation: necessary or not? Transplantation. 2007; 84 (12 Suppl): S40-S43.

  24. Stojanovic J, Adamusiak A, Kessaris N, Chandak P, Ahmed Z, Sebire NJ et al. Immune desensitization allows pediatric blood group incompatible kidney transplantation. Transplantation. 2017; 101 (6): 1242-1246.




2020     |     www.medigraphic.com